Your browser doesn't support javascript.
loading
ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma.
Arabzade, Amir; Zhao, Yanhua; Varadharajan, Srinidhi; Chen, Hsiao-Chi; Jessa, Selin; Rivas, Bryan; Stuckert, Austin J; Solis, Minerva; Kardian, Alisha; Tlais, Dana; Golbourn, Brian J; Stanton, Ann-Catherine J; Chan, Yuen San; Olson, Calla; Karlin, Kristen L; Kong, Kathleen; Kupp, Robert; Hu, Baoli; Injac, Sarah G; Ngo, Madeline; Wang, Peter R; De León, Luz A; Sahm, Felix; Kawauchi, Daisuke; Pfister, Stefan M; Lin, Charles Y; Hodges, H Courtney; Singh, Irtisha; Westbrook, Thomas F; Chintagumpala, Murali M; Blaney, Susan M; Parsons, Donald W; Pajtler, Kristian W; Agnihotri, Sameer; Gilbertson, Richard J; Yi, Joanna; Jabado, Nada; Kleinman, Claudia L; Bertrand, Kelsey C; Deneen, Benjamin; Mack, Stephen C.
Afiliação
  • Arabzade A; Department of Chemical and Biomolecular Engineering, Rice University, Houston, Texas.
  • Zhao Y; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Texas Children's Cancer and Hematology Centers, Dan L. Duncan Cancer Center, Houston, Texas.
  • Varadharajan S; Therapeutic Innovation Center at Baylor College of Medicine, Houston, Texas.
  • Chen HC; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Texas Children's Cancer and Hematology Centers, Dan L. Duncan Cancer Center, Houston, Texas.
  • Jessa S; Therapeutic Innovation Center at Baylor College of Medicine, Houston, Texas.
  • Rivas B; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Texas Children's Cancer and Hematology Centers, Dan L. Duncan Cancer Center, Houston, Texas.
  • Stuckert AJ; Therapeutic Innovation Center at Baylor College of Medicine, Houston, Texas.
  • Solis M; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Texas Children's Cancer and Hematology Centers, Dan L. Duncan Cancer Center, Houston, Texas.
  • Kardian A; Therapeutic Innovation Center at Baylor College of Medicine, Houston, Texas.
  • Tlais D; Cancer and Cell Biology Program, Baylor College of Medicine, Dan L. Duncan Cancer Center, Houston, Texas.
  • Golbourn BJ; Quantitative Life Sciences, McGill University, Montreal, Quebec, Canada.
  • Stanton AJ; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Texas Children's Cancer and Hematology Centers, Dan L. Duncan Cancer Center, Houston, Texas.
  • Chan YS; Therapeutic Innovation Center at Baylor College of Medicine, Houston, Texas.
  • Olson C; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Texas Children's Cancer and Hematology Centers, Dan L. Duncan Cancer Center, Houston, Texas.
  • Karlin KL; Therapeutic Innovation Center at Baylor College of Medicine, Houston, Texas.
  • Kong K; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Texas Children's Cancer and Hematology Centers, Dan L. Duncan Cancer Center, Houston, Texas.
  • Kupp R; Therapeutic Innovation Center at Baylor College of Medicine, Houston, Texas.
  • Hu B; Cancer and Cell Biology Program, Baylor College of Medicine, Dan L. Duncan Cancer Center, Houston, Texas.
  • Injac SG; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Texas Children's Cancer and Hematology Centers, Dan L. Duncan Cancer Center, Houston, Texas.
  • Ngo M; Therapeutic Innovation Center at Baylor College of Medicine, Houston, Texas.
  • Wang PR; Cancer and Cell Biology Program, Baylor College of Medicine, Dan L. Duncan Cancer Center, Houston, Texas.
  • De León LA; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Texas Children's Cancer and Hematology Centers, Dan L. Duncan Cancer Center, Houston, Texas.
  • Sahm F; Therapeutic Innovation Center at Baylor College of Medicine, Houston, Texas.
  • Kawauchi D; Department of Neurological Surgery, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Pfister SM; Department of Neurological Surgery, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Lin CY; Therapeutic Innovation Center at Baylor College of Medicine, Houston, Texas.
  • Hodges HC; Department of Molecular and Cellular Biology and Center for Precision Environmental Health, Baylor College of Medicine, Houston, Texas.
  • Singh I; Department of Bioengineering, Rice University, Houston, Texas.
  • Westbrook TF; Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chintagumpala MM; Therapeutic Innovation Center at Baylor College of Medicine, Houston, Texas.
  • Blaney SM; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
  • Parsons DW; Department of Biochemistry and Molecular Biology, Houston, Texas.
  • Pajtler KW; Therapeutic Innovation Center at Baylor College of Medicine, Houston, Texas.
  • Agnihotri S; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
  • Gilbertson RJ; Department of Biochemistry and Molecular Biology, Houston, Texas.
  • Yi J; Therapeutic Innovation Center at Baylor College of Medicine, Houston, Texas.
  • Jabado N; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, England.
  • Kleinman CL; Department of Oncology, University of Cambridge, Hutchison/MRC Research Centre, Cambridge Biomedical Campus, Cambridge, England.
  • Bertrand KC; Department of Neurological Surgery, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Deneen B; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Texas Children's Cancer and Hematology Centers, Dan L. Duncan Cancer Center, Houston, Texas.
  • Mack SC; Therapeutic Innovation Center at Baylor College of Medicine, Houston, Texas.
Cancer Discov ; 11(9): 2200-2215, 2021 09.
Article em En | MEDLINE | ID: mdl-33741710
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Neoplasias Supratentoriais / Proteínas de Ligação a DNA / Ependimoma / Fator de Transcrição RelA Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cancer Discov Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Neoplasias Supratentoriais / Proteínas de Ligação a DNA / Ependimoma / Fator de Transcrição RelA Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cancer Discov Ano de publicação: 2021 Tipo de documento: Article